Marino Garcia, CEO AND PRESIDENT at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 122,918 shares at $80.69 ($10.0M) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Open-market sale of $10.0M DNTH by CEO AND PRESIDENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.69 | 43,505 | $3.5M | 35.0% |
| 2 | $81.74 | 65,517 | $5.4M | 53.5% |
| 3 | $82.60 | 12,796 | $1.1M | 10.6% |
| 4 | $83.38 | 200 | $17K | 0.2% |
| 5 | $85.53 | 900 | $77K | 0.8% |
| Total | $81.49 avg | 122,918 |
| $10.0M |
| 100% |